Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Quantitative Analysis Of Cell-free DNA In The Plasma Of Gastric Cancer Patients.

Jong-lyul Park, H. Kim, B. Choi, Han-Chul Lee, Hay-Ran Jang, K. Song, Seung-Moo Noh, Seon-Young Kim, D. Han, Y. Kim
Published 2012 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
In the present study, an accurate and reproducible method for quantifying cell-free DNA (cfDNA) in human blood was established and tested for its ability to predict gastric cancer in patients. Using 'Alu81-qPCR' to amplify 81-bp Alu DNA sequences, we first estimated the amount of cfDNA in the serum or plasma of 130 patients with gastric cancer to identify which source of cfDNA is more suitable for the biomarker screening of these patients. The results of Alu81-qPCR revealed that the amount of cfDNA in the plasma was low compared with that in the serum, but was found at similar levels among the samples, indicating that the plasma may be a more suitable source of cfDNA for biomarker screening. For the 54 patients with gastric cancer and the 59 age-matched healthy controls, the mean levels of plasma cfDNA were 2.4-fold higher in the patient group compared with the control group, indicating that plasma cfDNA levels may be useful for predicting patients with gastric cancer. The results of our study suggest that Alu81-qPCR is a more reliable method than other techniques, such as the PicoGreen assay, for quantifying cfDNA in human blood, demonstrating the potential to complement current diagnostic procedures for the management of gastric cancer patients.
This paper references
The effect of inflammation on the generation of plasma DNA from dead and dying cells in the peritoneum
N. Jiang (2005)
Role of Cell‐Free Plasma DNA as a Diagnostic Marker for Prostate Cancer
D. Allen (2004)
Inflammation and Cancer: The Link Grows Stronger
J. Marx (2004)
Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR
S. Gal (2004)
Increased concentrations of cell-free plasma DNA after exhaustive exercise.
J. Atamaniuk (2004)
Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma
T. Lee (2001)
Effects of preanalytical factors on the molecular size of cell-free DNA in blood.
K. Chan (2005)
Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation.
Y. Lui (2002)
Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance.
E. Gormally (2007)
Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy.
O. Gautschi (2004)
Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool.
A. Pathak (2006)
Densities, length proportions, and other distributional features of repetitive sequences in the human genome estimated from 430 megabases of genomic sequence.
Z. Gu (2000)
Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.
J. Silva (2002)
Quantification of Circulating DNA in the Plasma and Serum of Cancer Patients
B. Taback (2004)
Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer
G. Sozzi (2003)
Quantification of plasma DNA as a screening tool for lung cancer.
Guang-shun Xie (2004)
Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma.
K. Chan (2008)
Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls.
M. B. Giacona (1998)
Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer.
H. Chang (2002)
Higher Amount of Free Circulating DNA in Serum than in Plasma Is Not Mainly Caused by Contaminated Extraneous DNA during Separation
N. Umetani (2006)
Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases.
Thijssen Ma (2002)
Global cancer statistics
A. Jemal (2011)
Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancer.
K. Jung (2004)
Global Cancer Statistics, 2002
D. Parkin (2005)
Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer
H. Schwarzenbach (2008)
Circulating mutant DNA to assess tumor dynamics
F. Diehl (2008)
Cell-free DNA in serum and plasma: comparison of ELISA and quantitative PCR.
S. Holdenrieder (2005)
Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases.
M. A. Thijssen (2002)
Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations.
J. Silva (1999)
Extracellular Circulating Nucleic Acids in Human Plasma in Health and Disease
P. Laktionov (2005)
Cancer research. Inflammation and cancer: the link grows stronger.
J. Marx (2004)
Free DNA in the serum of cancer patients and the effect of therapy.
S. León (1977)
Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours.
G. Fournié (1995)
DNA methylation biomarkers for blood-based colorectal cancer screening.
C. Lofton-Day (2008)

This paper is referenced by
Circulating Cell-Free DNA as a Prognostic and Molecular Marker for Patients with Brain Tumors under Perillyl Alcohol-Based Therapy
G. Faria (2018)
Plasma cell-free DNA in diagnostic KRAS mutation testing
A. Isomursu (2015)
Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA
Wang-yang Pu (2016)
Diagnostic and prognostic value of circulating tumor- related DNA in cancer
Diego M. Marzese (2013)
Comparison of Blood Collection Tubes from Three Different Manufacturers for the Collection of Cell-Free DNA for Liquid Biopsy Mutation Testing.
C. Alidousty (2017)
Current status of cell-free DNA in head and neck cancer management
A. Singhal (2019)
Acute Tumor Transition Angle on Computed Tomography Predicts Chromosomal Instability Status of Primary Gastric Cancer: Radiogenomics Analysis from TCGA and Independent Validation
Y. Lai (2019)
Cell-free DNA as a liquid biopsy for early detection of gastric cancer
Zhengbin Huang (2021)
Circulating Cell-Free Nucleic Acids as Potential Biomarkers for Noninvasive Diagnosis of Diseases in the Future
S. Pehlivan (2012)
Noninvasive detection of gastric cancer
Qin-Si Wan (2016)
The Ratio of ssDNA to dsDNA in Circulating Cell-Free DNA Extract is a Stable Indicator for Diagnosis of Gastric Cancer
Xuewen Huang (2020)
Circulating free DNA concentration as a marker of disease recurrence and metastatic potential in lung cancer
H. Mirtavoos-mahyari (2019)
Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review.
Klara Cervena (2019)
Circulating Tumor DNA: A Step into the Future of Cancer Management
Joana Fernandes Marques (2019)
A biocomposite-based rapid sampling assay for circulating cell-free DNA in liquid biopsy samples from human cancers
B. Koo (2020)
Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease
A. Szpechcinski (2015)
Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease.
I. Clark (2013)
Quantification of circulating plasma cell free DNA fragments in patients with oral cancer and precancer.
Ami P Desai (2018)
Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.
Z. Ye (2019)
Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant Diagnosis
W. Wang (2020)
Measurement of circulating tumor DNA to guide management of patients with lymphoma.
D. Sriram (2019)
Gastric Cancer Biomarkers in Circulation
G. Dakubo (2017)
Plasma vs. serum in circulating tumor DNA measurement: characterization by DNA fragment sizing and digital droplet polymerase chain reaction
J. Lee (2019)
Cell-free DNA testing: future applications in gastroenterology and hepatology
Inuk Zandvakili (2019)
Circulating DNA for detection of gastric cancer.
Q. Qi (2016)
Papel das biopsias líquidas no cancro esofágico, gástrico, pancreático e colo-retal
Tiago Costa (2017)
Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells
T. Li (2018)
Assessing Circulating Cell-free Tumour DNA as a Potential Biomarker for Early Detection and Chemoprevention of Colorectal Cancer
M. Myint (2017)
Liquid biopsies: genotyping circulating tumor DNA.
L. Diaz (2014)
Cell-free circulating tumor DNA in cancer
Zhen Qin (2016)
Circulating Tumor DNA as Biomarkers for Cancer Detection
Xiao Han (2017)
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.
E. Pectasides (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar